PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

PM360 Magazine, recently named DHIVY Marketing as one of five Trailblazer Marketing Team of the Year finalists.

DHIVY (carbidopa/levodopa segments 6.25mg/25mg I Tablets 25mg/100mg) is a new therapy for Parkinson’s Disease patients that is a functionally scored tablet that will provide personalized and precise daily dosing for people with Parkinson’s Disease

“We are excited to bring this new formulation to the market. This product was developed by two neurologists that witnessed a need for more precise dosing that can be taken as a whole tablet or in precise segments. This flexibility provides personalized dosing for each Parkinson’s patient. I am very proud of our marketing team for their accomplishments and this significant recognition”, said Shannon Faught, Alora Pharmaceuticals, Chief Commercial Officer

Since 2009, the PM360 Trailblazer Awards have recognized outstanding achievement and innovation in healthcare marketing. Each year, nominations are judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. The Marketing Team of the Year award honors a team that reaches across various functions to achieve exceptional results such as outstanding marketing practices, the adoption of new and innovative technologies/strategies, successfully positioning their brand/company, creating an outstanding customer experience, or positively impacting the culture of their organization.

“This year’s marketing team finalists helped to redefine paradigms within their respective disease areas,” says Anna Stashower, CEO and Publisher of PM360. “One team changed the national conversation around insomnia, another changed the way the world treats obesity, and yet another repositioned how HIV+ patients are viewed around the world. Understanding the emotional, psychological, and physical toll IBD patients experience, one team took a holistic approach to meeting their needs through a new kind of mentor program. And the final finalist worked with the Parkinson’s disease patient community to spread awareness of a new treatment that could fulfill an unmet need in their treatment. Ultimately, each of their efforts changed patient care for the better.”

Finalists are acknowledged and winners will be announced during a gala celebration at Gotham Hall in New York City on Thursday, September 22 from 6 pm to 12 am.